You just read:

Sutro ADCs Targeting CD74 Suppress Tumors in Multiple Malignant Cell Lines and Animal Models of Multiple Myeloma and Non-Hodgkin Lymphoma

News provided by

Sutro Biopharma Inc.

Sep 19, 2016, 08:00 ET